BioLargo Reports Third Quarter 2026 Results, Forecasting

New Post Public Reply Private Reply Replies (0) Message Board
louied91
45
BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027

https://www.accessnewswire.com/newsroom/en/ch...27-1252491  

Launches consumer products under its company-owned "barebird" brand featuring its CupriDyne technology; New distributors of Clyra Medical's ViaCLYR, pending 2027 new product line; BioLargo Engineering team grew revenue by 23% while also supporting PFAS and Cellinity projects; AEC PFAS treatment validated and prepared to support expanding sales pipeline; Annual Meeting of Stockholders to be held December 1, 2026, in Aliso Viejo, California.

WESTMINSTER, CA / ACCESS Newswire / November 17, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today reported financial results for the third quarter ended September 30, 2026, and provided an update on commercialization activities across its portfolio of companies. The company filed its Quarterly Report on Form 10-Q on November 16, 2026 (www.BioLargo.com/SEC-filings). The company will forego a quarterly earnings call, as its Annual Meeting of Stockholders will be held on December 1, 2026, in Aliso Viejo, California.

Net losses reflect continued investment in commercialization, led by Clyra Medical which accounted for $6.4 million (57%) of the nine-month net loss, as it invested in personnel, manufacturing, product development and clinical activities to support its distributors and prepare for the national rollout of an additional product line expected in 2027. Clyra financed this work largely through debt, which also increased interest expense.

"We've focused our energies on investing to ensure 2027 is a breakout year for BioLargo, with new medical product lines and selling channels, a new consumer product line just launched under our brand name ‘barebird', and we continue developing and expanding important commercial relationships in the water and energy industries," said Dennis P. Calvert, BioLargo CEO. "We built the channels, the supply chain and partnerships, and most of this work was funded inside the subsidiaries rather than the parent. That is why we expect in 2027 to shift our spending away from R&D and toward generating sales, as we move from developing products to selling them."

FINANCIAL RESULTS

Total revenue was $1,090,000 in the third quarter of 2026, against $1,103,000 a year earlier, a decrease of 1%. Service revenue increased 72% and product revenue decreased 32%. For the nine months, total revenue was $3,452,000 against $7,148,000, a decrease of 52%. Service revenue increased 23% and product revenue decreased 73%.

Net loss was $3,824,000 in the third quarter of 2026, against $7,244,000 a year earlier, a decrease of 47%. The decrease was primarily due to a credit loss expense incurred last year. For the nine months, net loss was $11,229,000 against $11,047,000, an increase of 2%. Clyra Medical accounted for approximately 57% of the consolidated net loss due to investments ahead of its 2027 product sales. The operating loss of BioLargo's corporate segment declined 27% for the nine months to $2,200,000 from $3,034,000.

Net cash used in operating activities was $8,182,000 for the nine months, compared with $6,707,000 in the same period of 2025, an increase of 22%. Within 2026, cash used in operations averaged roughly $736,000 per month in the third quarter, compared with roughly $996,000 per month in the first half, a decrease of approximately 26%. These amounts were funded primarily through Clyra Medical, which raised $4,299,000, primarily through a debt offering. Additionally, BioLargo's battery subsidiary (BETI) sold $487,000 in stock. 77% of the capital was raised at the subsidiary level and BioLargo corporate, in part through the Clearthink purchase agreement, sold $1,359,000 in common stock.

BUSINESS OPERATIONS AND UPDATES

Readying for a new product launch next year, Clyra has focused sales efforts so far in 2026 on establishing distribution of its ViaCLYR wound irrigation product, signing distribution agreements with Advanced Solution for the U.S., Al-Hikma FZCO for international, and Spartan Medical for U.S. Government and military.

Clyra has made significant investments in personnel, processes, and skilled manufacturing capabilities while advancing product design, market testing, and clinical activities, and has expanded its outreach to clinicians and its participation in industry meetings. The clinician feedback has been positive, helping the company expand its commercial reach into health systems around the country and, ultimately around the world. These initiatives are designed to support existing distributors and position the company for the national rollout of an additional product line in collaboration with a confidential strategic partner. That momentum includes Clyra satisfying a contractual milestone in the third quarter under an exclusive distribution agreement for certain of its products.

In October 2026, BioLargo launched the "barebird" branded consumer odor products (www.barebird.com) through a newly formed subsidiary BioLargo CPG LLC. Focusing on pet and laundry odors, the products have no need for fragrances and, "smell like nothing... on purpose", and feature BioLargo's proprietary CupriDyne Clean technology used to control odors in landfills and trash facilities. Digital marketing utilizing modern AI selling tools will help focus marketing dollars to optimize BioLargo's return on investment.

BioLargo's "Aqueous Electrostatic Concentrator" (AEC) has been removing PFAS from municipal drinking water in Lake Stockholm, New Jersey since January. Both the Environmental Protection Agency and the New Jersey equivalent continue to monitor the AEC's performance to ensure it meets state and federal standards. "Attention has historically focused on federal drinking-water rulemaking, and that market is very much alive. Lawsuit settlements in the billions of dollars are expected to fund PFAS treatment at public water systems, much of it for projects not yet underway, and we're well positioned to compete for that work," said Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, Inc. "But drinking water was never the whole market. The requirements aren't receding. Based on our observations, they're spreading to wastewater, landfill leachate, biosolids, industrial pre-treatment and shorter-chain compounds. Industry is also paying attention to more than regulation. These billion-dollar settlements address harm to communities and public health, and any operator with PFAS in its waste stream can see that exposure. Increasingly, they're choosing to treat at the source now, regardless of when federal enforcement arrives."

BioLargo has submitted bids and proposals and received indications of interest from a wide range of customer types, has added several high-profile industry experts to its team, and has entered into discussions about partnership and collaboration with industry-leading firms that have a gap in their PFAS treatment product lines. BioLargo management believes these opportunities represent strong avenues for accelerating adoption of BioLargo's AEC technology.

The company has other development stage ventures in its portfolio - BioLargo Energy focused on the Cellinity industrial grid-scale battery, and Tu Nipi focused on water treatment solutions to help manage Canadian oil sands tailings water - which are actively engaged in discussions with potential strategic partners to invest and work together to scale commercial operations.

"In every market we serve - PFAS removal, grid-scale energy storage, infection control and wound care, industrial and household odor control - customers have lived with the drawbacks of the incumbent technologies because there hasn't been a better option," said Calvert. "Our products and solutions are designed to be that option - for our customers and for the partners who sell them."

Stockholders are encouraged to read the Company's Quarterly Report on Form 10-Q in its entirety, including the financial statements, the accompanying notes, and the discussion of liquidity and capital resources, which contain information not included in this release.

ANNUAL MEETING OF STOCKHOLDERS: DECEMBER 1, 2026

BioLargo will hold its Annual Meeting of Stockholders on Tuesday, December 1, 2026, beginning at 10:00 a.m. Pacific Time in Aliso Viejo, California. Stockholders of record are urged to vote their shares and to attend. Details are set forth in BioLargo's proxy statement filed October 19, 2026, and stockholders may contact the Company at Info@BioLargo.com for additional information about the meeting.

BioLargo values the opportunity to connect with its stockholders in person. Anyone who expects to be in the area on December 1st is encouraged to reach out to the Company in advance at the email address above so that we can coordinate a chance to meet with members of the management team.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BVM's Brookfield Headquarters Move Tests Growth Ambition

Updated Category News Views 152

A bigger office is rarely the exciting part of a growth story, yet it can reveal whether the machinery underneath is actually running hot. Best Version Media has moved its headquarters from Janacek Court to 15800 W. Bluemound Road, Suite 400, in Brookfield, Wisconsin, citing room for recent hires, future recruitment and closer collaboration across its print and digital...

Continue Reading
Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 193

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 75

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
Rosengart's Repeat Honor Signals Litigation Bench Depth

Updated Category News Views 208

Hollywood lawsuits rarely stay tucked inside a filing cabinet; they spill into headlines, contracts, careers, and sometimes a company's whole public posture. That is why Mathew S. Rosengart landing on The Hollywood Reporter's Top 25 Legal Troubleshooters list for a second straight year is more than a pleasant plaque for the office wall. It is a reminder that, in media and...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 139

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 15

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 142

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 108

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading
Hot Dog Marketing Makes a Serious Public-Sector Push

Updated Category News Views 79

Five well-connected Central Texas names can tell you plenty about where an agency intends to hunt next. Hot Dog Marketing's Nov. 18 move is not some shiny rebrand with confetti tossed at the wall. The Austin-based firm is putting strategic communications beside its established marketing work and bringing in a five-member Strategic Advisory Council aimed squarely at...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 195

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading

Top 5 Most Recently Viewed Articles

Enveric Biosciences Expands Patent Portfolio for Drug Development

Updated Category News Views 76

Enveric Biosciences Expands Patent Protection for EVM301 Portfolio Enveric Biosciences (NASDAQ: ENVB) is making remarkable strides in the biotechnology sector with its commitment to developing novel neuroplastogens aimed at treating neuropsychiatric disorders. This dedication has led to the expansion of its patent portfolio with the issuance of five new U.S. patents, as...

Continue Reading
DTCC Enhances Global Operations with New Hyderabad Office

Updated Category News Views 394

DTCC Expands Horizons with New Office in Hyderabad The Depository Trust & Clearing Corporation (DTCC), a key player in post-trade market infrastructures for the global financial services sector, recently celebrated the grand opening of its new office in Hyderabad, India. This expansion underscores the company’s strategic commitment to enhancing its capabilities in a...

Continue Reading
Overview of Ericsson's Annual General Meeting in 2025

Updated Category News Views 231

Ericsson's Annual General Meeting Highlights Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) held its Annual General Meeting (AGM) in Kista, focusing on significant corporate matters that impact shareholders and the company's strategic direction. This meeting provided an essential platform for stakeholders to participate in decision-making processes, even offering postal...

Continue Reading
Prospera Energy Inc. Optimizes Production with Recent Updates

Updated Category News Views 430

Prospera Energy Inc. Optimizes Production Strategies CALGARY, Alberta - Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) is making significant strides in enhancing its operational efficiency and expanding its energy production capabilities. In an exciting update, the Corporation has provided crucial insights into its recent service rig operations, successful acquisitions,...

Continue Reading
Exploring Growth in the Clean Label Ingredients Industry

Updated Category News Views 287

The Clean Label Ingredients Market: A New Era of Transparency The global clean label ingredients market is flourishing as consumers increasingly seek natural food products. With the demand for preservative-free and organic food additives on the rise, the food industry is shifting dramatically. This transformation centers on enhancing transparency in food labeling and...

Continue Reading